Atlas Energy Solutions launched at Piper Sandler with an Overweight rating, attracted to multiple growth avenues, ...

Myriad Genetics (NASDAQ:MYGN) traded higher on Wednesday after Piper Sandler upgraded the cancer test developer to Overweight ...

Piper Sandler analyst Thomas Champion maintained a Buy rating on Zillow Group Class A (ZG – Research Report) today and set a price target of ...

In a report released today, Mark Lear from Piper Sandler maintained a Buy rating on Permian Resources (PR – Research Report), with a price ...

Charles Schwab Investment Management Inc. lowered its position in shares of Piper Sandler Companies (NYSE:PIPR – Free Report) by 0.1% in the fourth quarter, according to its most recent Form 13F ...

Asana (NYSE:ASAN – Get Free Report) had its price objective lowered by equities researchers at Piper Sandler from $27.00 to ...

Piper Sandler expects the bill to pass along party lines. "Once it makes it over to the Senate, at least eight Democrats will ...

Fintel reports that on March 12, 2025, Piper Sandler upgraded their outlook for Myriad Genetics (NasdaqGS:MYGN) from Neutral ...

Short sellers have been increasing their bets, with short interest now accounting for 6.1% of the stock's available float.

For two consecutive years, stock-market prognosticators lifted their outlooks for the S&P 500 Index over and over again to ...

Shares of Cava ( CAVA -4.74%) have had a great run over the past year and hit an all-time high of $172 in late 2024. But in ...

A chorus of Wall Street strategists is warning about rising volatility in the stock market, with Morgan Stanley’s Michael ...